| abstract |
The present invention describes new salts of ACE inhibitors with N5N'-dibenzylethylenediamine (abbr.: benzathine salts), a process for their preparation in crystal and amorphous forms by the reaction of two moles of ACE inhibitors with one mole of N,N'-dibenzylethylenediamine, a process for the preparation of pharmaceutical formulations containing these salts and their use for the treatment of cardiovascular diseases. |